Cystagon - direct healthcare professional communication (DHPC)

mercaptamine bitartrate

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): CYSTAGON (mercaptamine bitartrate)

Key facts

• Medicine name:
  Cystagon
• Active substance:
  mercaptamine bitartrate
• Therapeutic area (MeSH):
  Cystinosis
• Procedure number:
  EMEA/H/C/000125
• DHPC type:
  Quality defect
• Human ATC codes:
  A16AA04
• Dissemination date:
  15/02/2023